Table 3 Relationship of initial disease with each factor

Background

Age, median (IQR)

73.6

74.7

0.45

Sex (male/female)

19/0

15/5

0.047

Tumor location (anastomosis/others)

12/7

7/13

0.11

Interval, median (IQR)

47 (32–50)

14.5 (5.75–23.25)

<0.001

Reconstruction at initial gastrectomy (Billroth-I/others)

8/11

12/8

0.34

Tumor

pT (1/≥2)

9/10

6/14

0.33

pN (−/+)

14/5

16/4

0.72

pStage (I/≥II)

10/9

9/11

0.75

Histology (differentiated/undifferentiated type)

14/4

11/9

0.18

Ly (−/+)

6/13

6/14

1

V (−/+)

8/11

5/15

0.32

Post-surgery

Clavien-Dindo grade (≤II/≥III)

15/2

16/4

0.67

Adjacent organ resections,(−/+))

18/1

16/4

0.34

Adjuvant chemotherapy (−/+)

17/2

15/5

0.41

Sydney system

Inflammation (+/−)

18/1

19/1

1

Activity (+/−)

9/10

4/16

0.096

Atrophy (+/−)

16/3

17/3

1

Intestinal metaplasia (+/−)

7/12

5/15

0.50

H.Pylori (+/−)

9/10

3/17

0.041

Immunology, area index

CD8

3562

2243

0.046

CD4

30,419

16,614

0.15

FoxP3

16,725

7689

0.20

CD20

187,881

19,740

0.87